Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
08:55 - 09:00 5 mins
Logistics, Supply Chain, and Cryopreservation Techniques
Chairperson’s Opening remarks
  • Erik Woods - Co-Founder and Chief Science Officer, Ossium Health, Inc., USA
09:00 - 09:30 30 mins
Info
Logistics, Supply Chain, and Cryopreservation Techniques
Cryobiology – effects of freezing and thawing on cell viability
  • Mandana Haack-Sørensen - Head of Production, Rigshospitalet, Denmark
  • Case study on the effect freezing and thawing has on cell viability
  • how do you measure viability and what is the most reliable value?
09:30 - 10:00 30 mins
Info
Logistics, Supply Chain, and Cryopreservation Techniques
Adipose-derived Stromal Vascular Fraction for clinical use
  • Gianni Soldati - President, Swiss Stem Cell Foundation, Switzerland
  • Case study
10:00 - 10:30 30 mins
Info
Logistics, Supply Chain, and Cryopreservation Techniques
Developing a commercially viable, paper-free cryochain: a working model
  • Bill Shingleton - Alliances Manager, GE Asymptote, GE Healthcare Life Sciences
  • New, cost effective systems are needed to manufacture and deliver cell and gene therapies to patients.
  • GE Healthcare Lifesciences is part of joint venture with industry, academic and healthcare partners funded by Innovate UK. The projects aims to develop best practice for the safe and effective manufacturing and delivery of advanced therapies with traceability, trackable systems.
  • The VIA Freeze controlled rate freezers and VIA Thaw dry automated thawers with the my.Cryochain software system are embedded in Innovate UK’s ‘Advanced Therapies Treatment Centres’ project.
  • This case study will look at how these equipment are being used to deliver the project aims and the learnings so far to support scaling up to clinical studies and beyond
10:30 - 11:00 30 mins
Morning Coffee and Networking
11:00 - 11:30 30 mins
Logistics, Supply Chain, and Cryopreservation Techniques
Successful CAR-T delivery to the patient– quality perspectives on manufacturability & the supply chain
  • Sarah Snykers - QC Manager, Celyad, Belgium
11:30 - 12:00 30 mins
Logistics, Supply Chain, and Cryopreservation Techniques
Building Cell Therapy Supply Chain in Europe
  • Markwin Velders - VP Operations, Kite Pharma, The Netherlands
12:00 - 12:30 30 mins
Logistics, Supply Chain, and Cryopreservation Techniques
Cold Chain Management in a Cancer Center
  • Albert Ribickas - Bone Marrow Transplant Manager, Moffitt Cancer Center, USA
12:30 - 13:30 60 mins
Networking Luncheon in the Poster & Exhibition Hall
13:30 - 14:00 30 mins
Info
Logistics, Supply Chain, and Cryopreservation Techniques
Development, interpretation and assessment of freezing curves for cryopreservation of cellular therapeutics
  • Erik Woods - Co-Founder and Chief Science Officer, Ossium Health, Inc., USA
  • Controlled vs passive cryopreservation
  • Interpreting freeze curves
  • Assessment and quality control of cooling cycles
14:00 - 14:30 30 mins
Info
Logistics, Supply Chain, and Cryopreservation Techniques
Cryopreservation considerations when moving from clinical phase to commercial phase manufacturing
  • Carmen Brenner - QC Manager, Bone Therapeutics, Belgium
  • What is required when reaching marketing/commercial stage with regards to cryopreservation?
  • Small amount of doses vs. commercial scale amount
  • What considerations must be made?
  • Challenges and opportunities?
14:30 - 14:35 5 mins
Chairpersons Closing Remarks
14:35 - 14:40 5 mins
End of Conference